If recent industry-sponsored studies–no matter how poorly designed–are to be believed, the U.S. Food and Drug Administration will pretty much regulate the medical device industry into oblivion.
Yet, whatever concerns people have about the FDA, real and imagined, people still are solidly bullish about the global prospects of the medical device and diagnostics industry.
A new survey of 125 medtech executives found that 91% of them expected an increase in the compound annual growth rate in the next three years. The survey responses represented 89 companies in 16 countries.
"What did surprise us was the bullishness of the industry," said Daniel Matlis, president of Axendia, a life sciences consulting firm that conducted the survey. "And, yes, the industry has always been very positive and very forward looking and thinking, but in the current economic environment with some of the pressures that the industry is experiencing, we assumed that level of bullishness would be tempered, but it wasn't.". . .View Full Article
